You are here: All Products  > LianBio Acquires China Rights to ReViral's RSV Therapy in $119 Million Deal

LianBio Acquires China Rights to ReViral's RSV Therapy in $119 Million Deal

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.